Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.accesswire.com/845736/relief-therapeutics-enters-into-exclusive-us-license-and-supply-agreement-with-eton-pharmaceuticals-for-pku-golike
https://www.globenewswire.com/news-release/2024/03/22/2850741/0/en/Eton-Pharmaceuticals-Announces-Acquisition-of-PKU-GOLIKE-for-Phenylketonuria.html
https://www.globenewswire.com//news-release/2024/03/14/2846673/0/en/Eton-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2024/02/29/2838373/0/en/Eton-Pharmaceuticals-to-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-Thursday-March-14-2024.html
https://www.globenewswire.com//news-release/2024/02/21/2832591/0/en/Eton-Pharmaceuticals-Awarded-U-S-Patent-for-Proprietary-Hydrocortisone-Oral-Liquid-Formulation.html
https://www.globenewswire.com//news-release/2024/02/02/2822744/0/en/Eton-Pharmaceuticals-Announces-Commercial-Availability-of-Ultra-Rare-Disease-Product-Nitisinone-Capsules.html
https://www.globenewswire.com//news-release/2023/11/09/2777767/0/en/Eton-Pharmaceuticals-Reports-Third-Quarter-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2023/10/30/2769013/0/en/Eton-Pharmaceuticals-to-Report-Third-Quarter-2023-Financial-Results-on-Thursday-November-9-2023.html
https://www.globenewswire.com//news-release/2023/10/04/2754408/0/en/Eton-Pharmaceuticals-Announces-Acquisition-of-FDA-Approved-Ultra-Rare-Disease-Product-Nitisinone.html
https://www.globenewswire.com//news-release/2023/08/23/2730257/0/en/Eton-Pharmaceuticals-to-Present-at-the-H-C-Wainwright-25th-Annual-Global-Investment-Conference.html